收藏切换
Preferences for digital therapeutics products based on discrete choice experiments—taking hypertension management products as an example
收藏切换
Gao-yuan ZHANG, Qian LI, You-li HAN
Modern Preventive Medicine | 2026, 53(1) : 118 - 122
Less
收藏切换
Modern Preventive Medicine | 2026, 53(1): 118-122
• Primary Health Services •
Preferences for digital therapeutics products based on discrete choice experiments—taking hypertension management products as an example
Full
Gao-yuan ZHANG, Qian LI, You-li HAN
Affiliations
  • School of Public Health, Capital Medical University, Beijing 100069, China
Published: 2026-01-10 doi: 10.20043/j.cnki.MPM.202505394
Outline
收藏切换
Objective

To understand the public’s preferences and willingness to pay for digital therapeutics (DTx) products for chronic disease management.

Methods

Based on a discrete choice experiment, an online questionnaire survey was administered via Wenjuanxing in February to March 2025, targeting the adult working population with independent spending capacity across the country. The preference outcomes were analyzed using a mixed logit model.

Results

Higher product accuracy (β=1.006), greater ease of use (β=0.349), superior product efficacy (β=0.569), higher product risk (β=-2.104),significant long-term health benefits (β=0.670), and inclusion in the medical insurance reimbursement list (β=1.458)demonstrated substantial influence on respondents’ preferences (P<0.001). Specifically, compared with low-risk products,respondents’ willingness to pay for high-risk products decreased by 7 891 yuan, and coverage by the medical insurance reimbursement list increased willingness to pay by 5 466 yuan compared with no coverage.

Conclusion

It is necessary to improve the regulatory system for DTx, establish a multi-payment pattern with medical insurance payment as the core and a climate of paying for health value, enhance the usability of products, and ultimately promote the improvement of chronic disease management levels and the promotion of DTx.

Chronic disease  /  Digital therapeutics  /  Discrete choice experiment
张高源, 李倩, 韩优莉. 基于离散选择实验的数字疗法产品偏好研究——以高血压管理产品为例. 现代预防医学, 2026 , 53 (1) : 118 -122 . DOI: 10.20043/j.cnki.MPM.202505394
Gao-yuan ZHANG, Qian LI, You-li HAN. Preferences for digital therapeutics products based on discrete choice experiments—taking hypertension management products as an example[J]. Modern Preventive Medicine, 2026 , 53 (1) : 118 -122 . DOI: 10.20043/j.cnki.MPM.202505394
Year 2026 volume 53 Issue 1
8
4
Cite this Article
BibTeX
Article Info
doi: 10.20043/j.cnki.MPM.202505394
  • Receive Date:2025-05-24
  • Online Date:2026-11-02
  • Published:2026-01-10
Article Data
Affiliations
History
  • Received:2025-05-24
Funding
Affiliations
    School of Public Health, Capital Medical University, Beijing 100069, China
References
Share
https://castjournals.cast.org.cn/joweb/xdyfyx/EN/10.20043/j.cnki.MPM.202505394
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT